SCHEMBL6989271

SCHEMBL6989271

COCCc1cnn(-c2ccccc2)c1-c1ccc(=O)n(C(C)C)n1

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 2/20 0.36
MPO P05164 1/20 0.35
GAA P10253 1/20 0.34
ALDH1A1 P00352 5/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33
LMNA P02545 1/20 0.33
HTT P42858 1/20 0.33
MAPT P10636 1/20 0.33
PPARG P37231 1/20 0.33
BLM P54132 1/20 0.33
NCOA2 Q15596 1/20 0.33
NCOA1 Q15788 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6987843 0.79 HIF1A (0.43) HIF1AGAAALDH1A1TSHRMAPK1
SCHEMBL6984146 0.78 HIF1A (0.42) HIF1AGAAALDH1A1TSHRMAPK1
SCHEMBL6984135 0.78 TSHR (0.39) HIF1AMPOALDH1A1TSHRSMN1; SMN2
SCHEMBL6983980 0.77 HIF1A (0.40) HIF1AGAAALDH1A1SMN1; SMN2HTT
SCHEMBL6985009 0.76 ALDH1A1 (0.38) HIF1AALDH1A1TSHRSMN1; SMN2HRH3
SCHEMBL6984311 0.72 MAPK14 (0.44)
SCHEMBL6984199 0.71 NPC1 (0.42) HIF1AMPOGAAALDH1A1TSHR
SCHEMBL6981881 0.69 PDE10A (0.43) GAAALDH1A1TSHRLMNAHTT
SCHEMBL6986812 0.68 ALDH1A1 (0.40) GAAALDH1A1TSHRSMN1; SMN2LMNA
SCHEMBL6984055 0.68 TSHR (0.34) GAAALDH1A1TSHRMAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1313733-A1 PYRAZOLOPYRIDINE COMPOUND AND PHARMACEUTICAL USE THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-05-28 EP disclosed
WO-2002018382-A1 PYRAZOLOPYRIDINE COMPOUND AND PHARMACEUTICAL USE THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-07 WO disclosed